Consumer Health

Analgesics is expected to register moderate constant value growth in 2023. Though there was widespread severe flu in early 2023, cough and cold remedies are not expected to benefit to a huge degree, as most of these patients were hospitalised or put…

The harsh climatic conditions in Kuwait with extreme heat, rising pollution and large amounts of dust continue to play a key role in driving demand across key OTC categories, in particular analgesics and cough, cold and allergy (hay fever) remedies.…

In general, consumer health in Kazakhstan is performing well towards the end of the review period. However, high inflation, increases in the costs of raw materials for the production of medicines and changed or disrupted logistics/supply routes have…

Consumer health in Honduras experienced a year of growth in value terms in 2023 that was in line with the country's inflation. Categories such as analgesics, cough, cold and allergy (hay fever) remedies, dermatologicals, and sports nutrition…

Consumer health has seen demand dampened by consumers being confronted with very high inflation. The rate of 9.2% in 2022 was the highest experienced in decades. As a result, more consumers have been forced to prioritise household spending on…